These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3097703)

  • 1. Specific disruption of spatial behaviour in rats by central muscarinic receptor blockade.
    Willner P; Wise D; Ellis T
    Psychopharmacology (Berl); 1986; 90(2):229-35. PubMed ID: 3097703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chlordiazepoxide and sodium valproate in two tests of spatial behaviour.
    Willner P; Birbeck KA
    Pharmacol Biochem Behav; 1986 Oct; 25(4):747-51. PubMed ID: 3097678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic receptor blockade produces impairments in a sensorimotor subsystem for place navigation in the rat: evidence from sensory, motor, and acquisition tests in a swimming pool.
    Whishaw IQ; Tomie JA
    Behav Neurosci; 1987 Oct; 101(5):603-16. PubMed ID: 3675838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an inhibitor of GABA-aminotransferase (gamma-vinyl-GABA) on the spatial navigation deficit induced by muscarinic blockade.
    Mazurkiewicz M; Sirviö J; Riekkinen PJ
    Pharmacol Biochem Behav; 1992 Sep; 43(1):91-6. PubMed ID: 1409821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of increased serotonergic and decreased cholinergic activities on spatial navigation performance in rats.
    Riekkinen P; Jäkälä P; Sirviö J; Riekkinen P
    Pharmacol Biochem Behav; 1991 May; 39(1):25-9. PubMed ID: 1924509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
    Bymaster FP; Heath I; Hendrix JC; Shannon HE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):16-24. PubMed ID: 7901390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior.
    Riekkinen P
    Eur J Pharmacol; 1994 Sep; 262(1-2):77-90. PubMed ID: 7813581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment with a 5HT1A receptor agonist and a muscarinic acetylcholine receptor antagonist disrupts water maze navigation behavior.
    Riekkinen M; Sirviö J; Toivanen T; Riekkinen P
    Psychopharmacology (Berl); 1995 Nov; 122(2):137-46. PubMed ID: 8848529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the scopolamine stimulus in rats.
    Jung M; Perio A; Worms P; Biziere K
    Psychopharmacology (Berl); 1988; 95(2):195-9. PubMed ID: 3137597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scopolamine administered before and after training impairs both contextual and auditory-cue fear conditioning.
    Rudy JW
    Neurobiol Learn Mem; 1996 Jan; 65(1):73-81. PubMed ID: 8673409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin-dependent maintenance of spatial performance and electroencephalography activation after cholinergic blockade: effects of serotonergic receptor antagonists.
    Dringenberg HC; Zalan RM
    Brain Res; 1999 Aug; 837(1-2):242-53. PubMed ID: 10434009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic antagonists are anxiogenic in rats tested in the black-white box.
    Smythe JW; Murphy D; Bhatnagar S; Timothy C; Costall B
    Pharmacol Biochem Behav; 1996 May; 54(1):57-63. PubMed ID: 8728539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of infusion of cholinergic drugs into the prefrontal cortex area on delayed matching to position performance in the rat.
    Herremans AH; Hijzen TH; Welborn PF; Olivier B; Slangen JL
    Brain Res; 1996 Mar; 711(1-2):102-11. PubMed ID: 8680852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scopolamine and methylscopolamine differentially affect fixed-consecutive-number performance of male and female Wistar rats.
    van Haaren F; van Hest A; van Hattum T
    Pharmacol Biochem Behav; 1989 Jun; 33(2):361-5. PubMed ID: 2813474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic blockade and response timing in rats.
    Soffié M; Lejeune H
    Psychopharmacology (Berl); 1992; 106(2):215-20. PubMed ID: 1549649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scopolamine impairs response-to-change based on distal cues in the rat.
    Poucet B; Buhot MC
    Physiol Behav; 1989 Sep; 46(3):355-9. PubMed ID: 2623055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scopolamine disrupts place navigation in rats and humans: a translational validation of the Hidden Goal Task in the Morris water maze and a real maze for humans.
    Laczó J; Markova H; Lobellova V; Gazova I; Parizkova M; Cerman J; Nekovarova T; Vales K; Klovrzova S; Harrison J; Windisch M; Vlcek K; Svoboda J; Hort J; Stuchlik A
    Psychopharmacology (Berl); 2017 Feb; 234(4):535-547. PubMed ID: 27885411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central muscarinic blockade interferes with retrieval and reacquisition of active allothetic place avoidance despite spatial pretraining.
    Vales K; Stuchlik A
    Behav Brain Res; 2005 Jun; 161(2):238-44. PubMed ID: 15922050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial learning and memory following fimbria-fornix transection and grafting of fetal septal neurons to the hippocampus.
    Nilsson OG; Shapiro ML; Gage FH; Olton DS; Björklund A
    Exp Brain Res; 1987; 67(1):195-215. PubMed ID: 3622677
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.